LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Methylated DNA in Saliva Samples Predicts Likelihood of Developing Childhood Obesity

By LabMedica International staff writers
Posted on 16 Mar 2020
Print article
Image: The Oragene DNA saliva collection kit (Photo courtesy of DNA Genotek)
Image: The Oragene DNA saliva collection kit (Photo courtesy of DNA Genotek)
A study based on analysis of saliva samples supports the concept that determination of DNA methylation in salivary tissue can be used to predict the eventual development of obesity by Hispanic children.

Prior findings reported by investigators at Vanderbilt University Medical Center (Nashville, TN, USA) in non-obese preschool-aged Hispanic children identified 17 CpG dinucleotides (regions of DNA where a cytosine nucleotide is followed by a guanine nucleotide) for which differential methylation in saliva at baseline was associated with maternal obesity status. The current study investigated to what extent baseline DNA methylation in salivary samples in these three to five-year-old Hispanic children predicted the incidence of childhood obesity in a three-year prospective cohort.

For the study, the investigators examined 92 participants of the Growing Right Onto Wellness (GROW) trial who were randomly selected at baseline, prior to randomization, based on maternal phenotype (obese or non-obese). Baseline saliva samples were collected using the DNA Genotek (Ottawa, Canada) Oragene DNA saliva collection kit. Methylation arrays were processed using standard protocol. Associations between child obesity at 36 months and baseline salivary methylation at the previously identified 17 CpG dinucleotides were evaluated using multivariable logistic regression models. Objective data were collected on child height and weight at baseline and 36 months later.

Results, which demonstrated the utility of using saliva for epigenetic studies, revealed that methylation of the NRF1 gene was associated with childhood obesity. NRF1 (Nuclear respiratory factor 1) encodes a protein that functions as a transcription factor, which activates the expression of some key metabolic genes regulating cellular growth and nuclear genes required for respiration, heme biosynthesis, and mitochondrial DNA transcription and replication. A child with NRF1 methylation at baseline was found to have threefold increased odds of being obese three years later, after controlling for maternal BMI and other factors.

"At baseline, these children were all non-obese, but based on their maternal BMI, their DNA was methylated differently at 17 sites," said senior author Dr. Shari Barkin, professor of medicine at Vanderbilt University. "Now we know that some of them emerged into obesity. Most studies have looked for factors in children who are already obese. Our study demonstrates that there are already changes in the physiology - a pathway to obesity - even before the phenotype of obesity emerges. If we can define a predictive epigenetic signature, we can intervene earlier to reduce health disparities in common conditions like obesity."

The childhood obesity study was published in the February 14, 2020, online edition of the journal BMC Medical Genetics.

Related Links:
Vanderbilt University Medical Center
DNA Genotek


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more